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The GOLPH3 pathway regulates
Golgi shape and function and is
activated by DNA damage
Matthew D. Buschman †, Mengke Xing † and Seth J. Field *
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA, USA
The Golgi protein GOLPH3 binds to PtdIns(4)P and MYO18A, linking the Golgi to the
actin cytoskeleton. The GOLPH3 pathway is essential for vesicular trafficking from the
Golgi to the plasma membrane. A side effect of GOLPH3-dependent trafficking is to
generate the extended ribbon shape of the Golgi. Perturbation of the pathway results in
changes to both Golgi morphology and secretion, with functional consequences for the
cell. The cellular response to DNA damage provides an example of GOLPH3-mediated
regulation of the Golgi. Upon DNA damage, DNA-PK phosphorylation of GOLPH3
increases binding to MYO18A, activating the GOLPH3 pathway, which consequently
results in Golgi fragmentation, reduced trafficking, and enhanced cell survival. The
PtdIns(4)P/GOLPH3/MYO18A/F-actin pathway provides new insight into the relationship
between Golgi morphology and function, and their regulation.
Keywords: Golgi, phosphatidylinositol-4-phosphate, GOLPH3, MYO18A, secretory trafficking, DNA damage,
cancer, neurodegenerative disease
Introduction
In many mammalian cell types the Golgi complex appears by light microscopy as an extended
ribbon that wraps partially around the nucleus. The ribbon is composed of many subresolution
stacks of membrane (as observed by electron microscopy) that are linked via Golgi-associated
proteins. From first principles we can conclude that the steady-state appearance of the Golgi reflects
the balance of forces applied to it. Changes in the shape of the Golgi presumably reflect alterations
in the balance of forces applied to the Golgi. Since at least some of the forces that are applied to
the Golgi are likely to be important for its function in vesicle trafficking, changes in trafficking
machinery might be expected to lead to changes in Golgi morphology. However, it is important
to bear in mind that the morphology of the Golgi varies significantly across species (reviewed in
Mowbrey and Dacks, 2009; Wei and Seemann, 2010), suggesting that diverse morphologies can
still be fully competent for trafficking.
The GOLPH3 pathway provides a link from the trans-Golgi membrane to the actin cytoskeleton
that plays a critical role in anterograde trafficking to the plasma membrane (Figure 1). The trans-
Golgi is highly enriched in phosphatidylinositol-4-phosphate (PtdIns(4)P) (Godi et al., 1999, 2004).
In mammalian cells Golgi PtdIns(4)P is produced by the Golgi localized PI-4-kinases, PI-4-kinase-
IIIβ (PI4KIIIβ) and PI-4-kinase-IIα (PI4KIIα) (Wong et al., 1997; Wang et al., 2003; De Matteis
et al., 2005). PtdIns(4)P levels are reduced by the action of the Golgi/ER localized PtdIns(4)P-4-
phosphatase, SAC1 (Foti et al., 2001; Schorr et al., 2001). GOLPH3 localizes to the trans-Golgi via its
direct interaction with PtdIns(4)P (Dippold et al., 2009). This interaction is mediated by a binding
pocket on the hydrophobic face of GOLPH3. Furthermore, GOLPH3’s interaction with PtdIns(4)P
Buschman et al. GOLPH3 pathway regulates the Golgi
FIGURE 1 | Regulation of the Golgi via the GOLPH3 pathway. The
GOLPH3 pathway links the Golgi to the actin cytoskeleton, which applies a
tensile force to the Golgi that is essential for anterograde trafficking. The
GOLPH3 pathway is subject to regulation by different mechanisms. Growth
factor signaling increases Golgi PtdIns(4)P levels through translocation of
SAC1 away from the Golgi to the ER (Blagoveshchenskaya et al., 2008).
GOLPH3L is a GOLPH3 paralog that acts as a dominant negative inhibitor of
the GOLPH3 pathway due to its ability to bind to PtdIns(4)P, while being
unable to bind to MYO18A (Ng et al., 2013). GOLPH3L acts as a throttle to
Golgi-to-plasma membrane trafficking in highly secretory cells. Upon DNA
damage, DNA-PK activates the pathway by phosphorylation of GOLPH3 to
enhance its interaction with MYO18A (Farber-Katz et al., 2014).
and its Golgi localization are conserved from yeast to humans
(Dippold et al., 2009; Wood et al., 2009). GOLPH3 also binds
tightly and specifically to the unconventional myosin, Myosin
18A (MYO18A) (Dippold et al., 2009; Ng et al., 2013; Taft
et al., 2013; Farber-Katz et al., 2014), and MYO18A has been
shown to bind to F-actin (Isogawa et al., 2005; Guzik-Lendrum
et al., 2013; Taft et al., 2013). Thus, GOLPH3/MYO18A serves
to link the PtdIns(4)P-rich trans-Golgi membrane to the actin
cytoskeleton.
Perturbations of the GOLPH3 Pathway
Alter Trafficking and Golgi Morphology
All of the components of the pathway, PtdIns(4)P, GOLPH3,
MYO18A, and F-actin, are required for efficient Golgi-to-plasma
membrane trafficking. PtdIns(4)P has been shown to be required
for Golgi secretory function across species from yeast to humans
(Hama et al., 1999; Walch-Solimena and Novick, 1999; Audhya
et al., 2000; Wang et al., 2003). Likewise, GOLPH3 and MYO18A
are required for Golgi-to-plasma membrane trafficking as
measured by VSVG delivery to the plasma membrane (Dippold
et al., 2009), total secretory flux by pulse-chase analysis (Ng et al.,
2013), secretion of hepatitis C viral particles (Bishé et al., 2012),
and for exit of anterograde trafficking vesicles from the Golgi
(Dippold et al., 2009). Finally, F-actin has been demonstrated to
be required for Golgi secretory function (Hirschberg et al., 1998;
Lázaro-Diéguez et al., 2007). Taken together, the data indicate
that the majority of trafficking from the Golgi to the plasma
membrane depends on the PtdIns(4)P/GOLPH3/MYO18A/F-
actin pathway.
FIGURE 2 | Perturbations of the GOLPH3 pathway alter Golgi
morphology. Examples of the Golgi (in red, co-stained with the nucleus in
blue) are shown under normal conditions and in response to perturbations to
interfere with or to increase the activity of the GOLPH3 pathway. Normally the
Golgi appears as an extended ribbon partially wrapped around the nucleus
(middle). Inhibition of the GOLPH3 pathway, by overexpression of SAC1
(Dippold et al., 2009), siRNA knockdown of GOLPH3 or MYO18A (Dippold
et al., 2009; Ng et al., 2013; Farber-Katz et al., 2014), overexpression of
GOLPH3L (Ng et al., 2013), or depolymerization of actin (Dippold et al., 2009),
results in compaction of the Golgi (left). Activation of the GOLPH3 pathway, by
overexpression of PI4KIIIβ (Hausser et al., 2005) or GOLPH3 (Ng et al., 2013),
siRNA knockdown of SAC1 (Liu et al., 2008) or GOLPH3L (Ng et al., 2013), or
in response to DNA damage (Farber-Katz et al., 2014), results in extension and
dispersal of the Golgi (right).
Depletion of PtdIns(4)P, GOLPH3, MYO18A, or F-actin
results in both a defect in Golgi-to-plasma membrane trafficking
and also a striking change in the morphology of the Golgi
(Figure 2). The normal Golgi ribbon that extends partially
around the nucleus condenses into a compact ball at one end
of the nucleus upon interference with any component of the
GOLPH3 pathway. For example, depletion of PtdIns(4)P by
overexpression of SAC1, siRNA knockdown of GOLPH3 or
MYO18A, or depolymerization of F-actin by latrunculin B, all
cause Golgi compaction (Dippold et al., 2009). From this and
other data (see Dippold et al., 2009) we infer that normally the
GOLPH3 pathway exerts a tensile force upon the Golgi that
contributes to stretching the Golgi around the nucleus. However,
the fact that the GOLPH3 pathway is conserved across species,
even those with dramatically different Golgi morphologies,
suggests that imparting this shape is not the primary role of
the pathway, but rather is a side-effect of its role in GOLPH3-
dependent Golgi-to-plasma membrane trafficking.
While interfering with the GOLPH3 pathway results in Golgi
compaction, increasing the activity of the GOLPH3 pathway
causes expansion of the Golgi (Figure 2). For example, mild
overexpression of GOLPH3 leads to an increasingly extended
Golgi ribbon. However, very high levels of overexpression of
GOLPH3 result in fragmentation and dispersal of the Golgi
throughout the cytoplasm (Ng et al., 2013). Likewise, an increase
in PtdIns(4)P at the Golgi by knockdown of SAC1 (Liu et al.,
2008) or overexpression of PI4KIIIβ (Hausser et al., 2005) also
result in increasing Golgi extension and even dispersal of the
Golgi. Moderate increases in GOLPH3 pathway activity lead to
Golgi extension and mild increases in anterograde trafficking.
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However, large increases in GOLPH3 pathway activity result in
dramatic Golgi fragmentation and impaired trafficking (Ng et al.,
2013; Farber-Katz et al., 2014).
Regulation of Golgi Morphology and
Function via the GOLPH3 Pathway
A growing body of evidence demonstrates regulation of Golgi
morphology and function via the GOLPH3 pathway (Figure 1).
For example, growth factor signaling regulates PtdIns(4)P levels
at the Golgi by regulating SAC1 localization. In response to
growth factor signaling, activated p38/MAPK phosphorylates
SAC1, causing it to translocate from the Golgi to the ER
(Blagoveshchenskaya et al., 2008). The resulting reduction of
PtdIns(4)P-4-phosphatase activity at the Golgi leads to a rise in
Golgi PtdIns(4)P levels, with a consequent increase in Golgi-to-
plasma membrane trafficking and extension and dispersal of the
Golgi.
The Golgi is also regulated by GOLPH3L, a paralog of
GOLPH3 that is expressed in highly secretory cells in vertebrates
(Ng et al., 2013). GOLPH3L binds to PtdIns(4)P and localizes
to the Golgi similarly to GOLPH3. However, unlike GOLPH3,
GOLPH3L does not bind to MYO18A, and thus acts as
an endogenous dominant-negative inhibitor of the GOLPH3
pathway. Our evidence suggests that GOLPH3L acts as a
throttle in highly secretory cells to prevent overly aggressive
anterograde trafficking. Correspondingly, overexpression of
GOLPH3L impairs GOLPH3 pathway function, resulting in
Golgi compaction and impaired Golgi-to-plasma membrane
trafficking. Knockdown of GOLPH3L results in dramatic
Golgi dispersal and impaired Golgi-to-plasma membrane
trafficking, similar to the effect of dramatic overexpression of
GOLPH3.
Regulation of the Golgi by DNA Damage
via the GOLPH3 Pathway
A recent study by our lab identified novel signaling that regulates
the Golgi in response to DNA damage (Farber-Katz et al., 2014).
We found that DNA damage triggers dramatic fragmentation
and dispersal of the Golgi. The mechanism involves activation
of the GOLPH3 pathway. In response to DNA damage, the DNA-
damage response kinase, DNA-PK, phosphorylates GOLPH3 on
a conserved TQ motif. The phosphorylation of GOLPH3, in
turn, enhances its physical interaction with MYO18A, increasing
GOLPH3 pathway-dependent vesiculation of the Golgi. As a
consequence of this increased GOLPH3/MYO18A interaction,
the Golgi undergoes dramatic fragmentation and dispersal,
resulting in impaired Golgi-to-plasma membrane trafficking.
Thus, DNA damage regulates Golgi shape and function by
activating the GOLPH3 pathway.
DNA damage has been posited to contribute to the
pathophysiology of many human diseases, including cancer
(reviewed in Lord and Ashworth, 2012) and neurodegenerative
diseases (reviewed in Madabhushi et al., 2014). Whether DNA
damage-induced regulation of the Golgi contributes to the
pathophysiology of these diseases remains unknown.
Relationship between Golgi Morphology
and Secretory Function
While perturbations of the GOLPH3 pathway result in
predictable and consistent changes in both Golgi shape
and secretory function, it does not follow that there is a
simple relationship between morphology and function. In fact,
perturbations of pathways other than the GOLPH3 pathway
have been demonstrated to alter Golgi morphology without
affecting secretory trafficking. For example, depolymerization
of microtubules by treatment with nocodazole leads to Golgi
fragmentation and dispersal (Thyberg and Moskalewski, 1999),
but does not alter secretory trafficking (Hirschberg et al., 1998).
Similarly, depletion of Rab29, or inhibition of Rab29 function
by overexpression of the inactive mutant Rab29-T21N results in
fragmentation of the Golgi (Wang et al., 2014). However, despite
the dramatic change in Golgi morphology, no change is observed
in trafficking of VSVG to the plasma membrane.
Thus, we conclude that there is not a simple relationship
between Golgi morphology and secretory function that holds
under all circumstances. Instead, the effect of a perturbation
on the Golgi is dictated by the specific mechanism of the
perturbation. However, for perturbations of the GOLPH3
pathway the consequences to Golgi morphology and secretory
function are predictable.
Functional Consequences of Altered Golgi
Since changes in Golgi morphology do not directly relate to
its trafficking function, it remains unclear whether changes in
Golgi morphology always have cellular consequences. However,
it seems safe to predict that perturbations of the Golgi that affect
Golgi-to-plasma membrane trafficking will have consequences
to the cell. The phenotypes associated with perturbation of the
GOLPH3 pathway provide strong examples of the importance
of Golgi-to-plasma membrane trafficking to overall cell and
organismal biology. Notably, GOLPH3 is an oncogene that is
frequently amplified and overexpressed in human cancers, and its
increased expression predicts poor patient prognosis (Scott et al.,
2009 and reviewed in Buschman et al., 2015). Furthermore, other
components of the GOLPH3 pathway have been implicated in
oncogenesis as well. Increased expression of PI4KIIα protein and
PI4KIIIβmRNAhave been detected in cancer cells (Li et al., 2010;
Curtis et al., 2012). A recent unbiased computational analysis
of data from The Cancer Genome Atlas for breast cancer has
identified MYO18A as a cancer driver (Sanchez-Garcia et al.,
2014).
PtdIns(4)P and GOLPH3 have been demonstrated to play
important roles in regulating cell motility. Knockdown of
SAC1, resulting in elevated Golgi PtdIns(4)P levels, leads to
increased cell migration (Tokuda et al., 2014). Conversely,
knockdown of PI4KIIIβ, resulting in a reduction of Golgi
PtdIns(4)P levels, impairs cell migration. These consequences of
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modulation of PtdIns(4)P levels are mediated by its downstream
effector GOLPH3. Likewise, perturbation of GOLPH3 itself
results in similar effects on cell migration. Increased GOLPH3
promotes cell migration and invasion, while depletion of
GOLPH3 impairs cell migration (Isaji et al., 2014; Tokuda et al.,
2014).
Our recent study on GOLPH3-mediated Golgi
dispersal/fragmentation upon DNA damage has revealed
an interesting role of the pathway in promoting cell survival
(Farber-Katz et al., 2014). We have demonstrated that the
GOLPH3-dependent Golgi response to DNA damage is
functionally important for cell survival after DNA damage.
Depletion of GOLPH3, MYO18A, or DNA-PKcs not only
prevents dispersal of the Golgi, but also significantly increases
apoptosis and reduces cell survival after treatment with DNA-
damaging agents. Conversely, overexpression of GOLPH3
confers a survival advantage to cells after DNA damage.
Importantly, this survival advantage caused by GOLPH3
overexpression requires both GOLPH3 localization to the Golgi
and its phosphorylation by DNA-PK. Altered Golgi-to-plasma
membrane trafficking that occurs upon Golgi fragmentation
after DNA damage is believed to be important for the enhanced
survival benefit provided by this pathway, although the critical
cargoes have not been identified as of yet. The DNA damage
response is a well-known driver of cancer progression (reviewed
in Lord and Ashworth, 2012). In addition, the resilience
against DNA damage conferred by overexpression of GOLPH3
has particular relevance to cancer, as most standard cancer
therapeutic regimens include DNA-damaging agents. Therefore,
our findings raise hope of using GOLPH3 expression levels as
a clinical marker to predict responsiveness to DNA-damaging
cancer therapies. Furthermore, novel agents to interfere with
the GOLPH3 pathway may have therapeutic benefit when used
in combination with standard DNA-damaging therapeutic
agents.
Potential Role of the GOLPH3 Pathway in
Neurodegenerative Disease
Whether the GOLPH3 pathway plays a role in the
pathophysiology of neurodegenerative disease has not been
studied. However, some of the known pathophysiology of
neurodegenerative disease makes it reasonable to speculate that
the GOLPH3 pathway may be involved. First, dysregulation
of the Golgi is a common feature of a variety of human
neurodegenerative diseases, including amyotrophic lateral
sclerosis, Parkinson’s disease, and Alzheimer’s disease. The
accompanying articles in this issue of Frontiers in Neuroscience
provide detailed reviews of the literature implicating Golgi
dysregulation in neurodegenerative disease. We note that the
changes in Golgi morphology that are associated with these
diseases mimic those seen with perturbations of the GOLPH3
pathway. Moreover, knockout of a Golgi-specific PI-4-kinase,
PI4KIIα, expected to interfere with GOLPH3 pathway function,
leads to late onset neurodegenerative disease in mice (Simons
et al., 2009). These knockout mice develop cerebellar Purkinje
cell loss and spinal cord axonal degeneration, which closely
resembles hereditary spastic paraplegia. Thus, there is at
least reason to speculate a role for the GOLPH3 pathway in
neurodegenerative disease.
A second link to the GOLPH3 pathway arises from a
substantial body of literature implicating the DNA damage
response in neurodegenerative disease. Loss-of-function
mutations in various DNA damage repair genes cause a range
of neurodegenerative diseases (Madabhushi et al., 2014). For
example, the DNA damage activated protein kinases ATM and
ATR (paralogs of DNA-PK) are mutated in ataxia-telangectasia
and ATR-Seckel syndrome, respectively (McKinnon, 2012).
Recent data indicate that DNA breaks occur frequently in
neurons (Madabhushi et al., 2015), bolstering the concern that
dysregulated DNA damage repair may contribute to disease in
neurons.
Our discovery that the Golgi is regulated in response to
DNA damage via DNA-PK activation of the GOLPH3 pathway
provides a plausible link between the evidence implicating DNA
damage and altered Golgi function in neurodegenerative disease.
Concluding Remarks
The appearance of the Golgi, at least in part, is a consequence
of the forces that act on it for vesicle trafficking. The GOLPH3
pathway, in particular, demonstrates the relationship between
Golgi secretory function and Golgi morphology. As might
be expected for a pathway with an important role in Golgi
function, the GOLPH3 pathway is a target for regulation
by multiple signals. For example, the GOLPH3 pathway is
activated in response to DNA damage, with consequences for
Golgi shape and trafficking function, as well as cell survival.
Since many proteins depend on trafficking from the Golgi
for their function, alterations in GOLPH3-dependent Golgi-
to-plasma membrane trafficking have pleiotropic effects on
cellular function, significantly impacting biology and human
pathophysiology.
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